Article
De novo DNMTs and DNA methylation: novel insights into disease pathogenesis and therapy from epigenomics.
Current pharmaceutical design - 1 Jan 2014
Leppert Sylwia, Matarazzo Maria R
Abstract excerpt
DNA methylation plays an important role in epigenetics signaling, having an impact on gene regulation, chromatin structure and development. Within the family of de novo DNA methyltransferases two active enzymes, DNMT3A and DNMT3B, are responsible for the establishment of the proper cytosine methylation profile during development. Defects in DNMT3s function correlate with pathogenesis and progression of monogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
